These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38697615)

  • 61. The impact of tranexamic acid on mortality in injured patients with hyperfibrinolysis.
    Harvin JA; Peirce CA; Mims MM; Hudson JA; Podbielski JM; Wade CE; Holcomb JB; Cotton BA
    J Trauma Acute Care Surg; 2015 May; 78(5):905-9; discussion 909-11. PubMed ID: 25909408
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Tranexamic acid in bleeding trauma patients: an exploration of benefits and harms.
    Roberts I; Edwards P; Prieto D; Joshi M; Mahmood A; Ker K; Shakur H
    Trials; 2017 Jan; 18(1):48. PubMed ID: 28143564
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Uncritical use of tranexamic acid in trauma patients : Do no further harm!].
    Maegele M
    Unfallchirurg; 2016 Nov; 119(11):967-972. PubMed ID: 27638555
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Efficacy and Safety of Tranexamic Acid in Prehospital Traumatic Hemorrhagic Shock: Outcomes of the Cal-PAT Study.
    Neeki MM; Dong F; Toy J; Vaezazizi R; Powell J; Jabourian N; Jabourian A; Wong D; Vara R; Seiler K; Pennington TW; Powell J; Yoshida-McMath C; Kissel S; Schulz-Costello K; Mistry J; Surrusco MS; O'Bosky KR; Van Stralen D; Ludi D; Sporer K; Benson P; Kwong E; Pitts R; Culhane JT; Borger R
    West J Emerg Med; 2017 Jun; 18(4):673-683. PubMed ID: 28611888
    [TBL] [Abstract][Full Text] [Related]  

  • 65. No Difference in Blood Loss and Risk of Transfusion Between Patients Treated with One or Two Doses of Intravenous Tranexamic Acid After Simultaneous Bilateral TKA.
    Wilde JM; Copp SN; Ezzet KA; Rosen AS; Walker RH; McCauley JC; Evans AS; Bugbee WD
    Clin Orthop Relat Res; 2022 Apr; 480(4):702-711. PubMed ID: 35302971
    [TBL] [Abstract][Full Text] [Related]  

  • 66. CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage) intracranial bleeding study: the effect of tranexamic acid in traumatic brain injury--a nested randomised, placebo-controlled trial.
    Perel P; Al-Shahi Salman R; Kawahara T; Morris Z; Prieto-Merino D; Roberts I; Sandercock P; Shakur H; Wardlaw J
    Health Technol Assess; 2012; 16(13):iii-xii, 1-54. PubMed ID: 22417901
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Population pharmacokinetics and pharmacodynamics of Tranexamic acid in women undergoing caesarean delivery.
    Li S; Ahmadzia HK; Guo D; Dahmane E; Miszta A; Luban NLC; Berger JS; James AH; Wolberg AS; van den Anker JN; Gobburu JVS
    Br J Clin Pharmacol; 2021 Sep; 87(9):3531-3541. PubMed ID: 33576009
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pharmacokinetics of tranexamic acid during cardiopulmonary bypass.
    Dowd NP; Karski JM; Cheng DC; Carroll JA; Lin Y; James RL; Butterworth J
    Anesthesiology; 2002 Aug; 97(2):390-9. PubMed ID: 12151929
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of Tranexamic Acid on Prevention of Hemorrhagic Mass Growth in Patients with Traumatic Brain Injury.
    Fakharian E; Abedzadeh-Kalahroudi M; Atoof F
    World Neurosurg; 2018 Jan; 109():e748-e753. PubMed ID: 29074420
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Avoidable mortality from giving tranexamic acid to bleeding trauma patients: an estimation based on WHO mortality data, a systematic literature review and data from the CRASH-2 trial.
    Ker K; Kiriya J; Perel P; Edwards P; Shakur H; Roberts I
    BMC Emerg Med; 2012 Mar; 12():3. PubMed ID: 22380715
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Increased risk of fibrinolysis shutdown among severely injured trauma patients receiving tranexamic acid.
    Meizoso JP; Dudaryk R; Mulder MB; Ray JJ; Karcutskie CA; Eidelson SA; Namias N; Schulman CI; Proctor KG
    J Trauma Acute Care Surg; 2018 Mar; 84(3):426-432. PubMed ID: 29298240
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Alternative routes for tranexamic acid treatment in obstetric bleeding (WOMAN-PharmacoTXA trial): a randomised trial and pharmacological study in caesarean section births.
    Shakur-Still H; Roberts I; Grassin-Delyle S; Chaudhri R; Geer A; Arribas M; Lamy E; Mansukhani R; Lubeya MK; Javaid K; Kayani A; Israr N; Mazhar SB; Urien S; Bouazza N; Foissac F; Prowse D; Carrington L; Barrow C; Onandia JG; Balogun E
    BJOG; 2023 Sep; 130(10):1177-1186. PubMed ID: 37019443
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evaluation of tranexamic acid in trauma patients: A retrospective quantitative analysis.
    Ng M; Perrott J; Burgess S
    Am J Emerg Med; 2019 Mar; 37(3):444-449. PubMed ID: 29903672
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Oral tranexamic acid for an additional 24 hours postoperatively versus a single preoperative intravenous dose for reducing blood loss in total knee arthroplasty: results of a randomized controlled trial (TRAC-24).
    Magill P; Hill JC; Bryce L; Martin U; Dorman A; Hogg R; Campbell C; Gardner E; McFarland M; Bell J; Benson G; Beverland D
    Bone Joint J; 2021 Oct; 103-B(10):1595-1603. PubMed ID: 34587808
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Use of tranexamic acid in trauma patients requiring massive transfusion protocol activation: an audit in a major trauma centre in New Zealand.
    Chapman N
    N Z Med J; 2018 Oct; 131(1483):8-12. PubMed ID: 30286060
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Prehospital administration of tranexamic acid in trauma patients.
    Wafaisade A; Lefering R; Bouillon B; Böhmer AB; Gäßler M; Ruppert M;
    Crit Care; 2016 May; 20(1):143. PubMed ID: 27176727
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Impact of Early Tranexamic Acid Administration on Overall Blood Product Utilization at 24 Hours.
    Douglas A; Faviere D; Gallo A; VanderSchaaf A; Wall W; Wilson K; Young A
    J Trauma Nurs; 2020; 27(2):66-70. PubMed ID: 32132483
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Intravenous Tranexamic Acid for Brain Contusion with Intraparenchymal Hemorrhage: Randomized, Double-Blind, Placebo-Controlled Trial.
    Mousavinejad M; Mozafari J; Ilkhchi RB; Hanafi MG; Ebrahimi P
    Rev Recent Clin Trials; 2020; 15(1):70-75. PubMed ID: 31744452
    [TBL] [Abstract][Full Text] [Related]  

  • 79. What concentration of tranexamic acid is needed to inhibit fibrinolysis? A systematic review of pharmacodynamics studies.
    Picetti R; Shakur-Still H; Medcalf RL; Standing JF; Roberts I
    Blood Coagul Fibrinolysis; 2019 Jan; 30(1):1-10. PubMed ID: 30585835
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Early tranexamic acid administration ameliorates the endotheliopathy of trauma and shock in an in vitro model.
    Diebel LN; Martin JV; Liberati DM
    J Trauma Acute Care Surg; 2017 Jun; 82(6):1080-1086. PubMed ID: 28328682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.